Literature DB >> 21917743

Inferior vena cava bypass for the treatment of obliterative hepatocavopathy with five-year follow-up.

Javier E Anaya-Ayala1, Brett A Johnson, Christopher J Smolock, Mark G Davies, Eric K Peden.   

Abstract

Inferior vena cava (IVC) thrombosis at its hepatic portion (also known as obliterative hepatocavopathy [OH]), in the absence of systemic or local diseases such as vasculitis, coagulopathy, infection and malignancy, is a rare event. We report the case of a 25-year-old woman with progressive abdominal pain and leg edema after exercise. Imaging showed congestive liver and IVC occlusion at the intrahepatic portion. A liver biopsy demonstrated portal congestion without evidence of fibrosis; after unsuccessful percutaneous attempts for recanalization, consideration was given to liver transplantation with IVC reconstruction versus IVC bypass. Due to the presence of preserved liver function, an externally supported 16-mm ringed polytetrafluoroethylene graft was used to bypass from the suprarenal IVC to the suprahepatic IVC. At five years, she remains symptom-free, with normal liver function and a patent graft on systemic anticoagulation. This report highlights the successful surgical management of a patient with OH with a thick membrane. It supports other published proposals that this entity differs significantly from classic Budd-Chiari syndrome with thrombosis that affects only the hepatic veins and, thus, OH should be approached and managed differently.

Entities:  

Mesh:

Year:  2011        PMID: 21917743     DOI: 10.1258/vasc.2011.cr0262

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  1 in total

1.  Endovascular recanalisation of a chronic occlusion of the retrohepatic IVC associated to a filter in a patient with antiphospholipid syndrome.

Authors:  Carlos A Hinojosa; Rene Lizola; Hugo Laparra-Escareno; Javier E Anaya-Ayala
Journal:  BMJ Case Rep       Date:  2017-04-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.